MannKind Corp (MNKD)

4.56 +0.01  +0.22% NASDAQ Oct 26, 10:00 USD
View Full Chart
Price Chart
View All MNKD News

News

View All Events

Events

Date Type Description
11/04/2021 Earnings Results Q3 2021 Earnings Results
11/04/2021 17:00 EST Earnings Calls Q3 2021 Earnings Call
08/11/2021 Earnings Results Q2 2021 Earnings Results
08/11/2021 17:00 EST Earnings Calls Q2 2021 Earnings Call
05/20/2021 11:00 EST AGM 2020 Annual General Meeting
05/12/2021 Earnings Results Q1 2021 Earnings Results
05/12/2021 17:00 EST Earnings Calls Q1 2021 Earnings Call
02/25/2021 Earnings Results Q4 2020 Earnings Results
02/25/2021 09:00 EST Earnings Calls Q4 2020 Earnings Call
11/04/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
  • URL: https://www.mannkindcorp.com
  • Investor Relations URL: https://investors.mannkindcorp.com
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 04, 2021
  • Last Earnings Release: Aug. 11, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.